Tarsier pharma will be participating at the 17th International Ocular Inflammation Society (IOIS) congress, taking place on September 6-9, 2023 in Berlin.
During this conference:
- Professor Quan Dong Nguen, Professor Marc de Smet, and Dr. David Chu will host a breakfast event to discuss the latest data from our TRS4Vision phase 3 trial.
- Daphne Haim-Langford, Tarsier Pharma’s CEO and Chairperson, will be featured as a panelist.
- Professor Itay Chowers will deliver a presentation based on his article “Suppression of Inflammation for Treating Diabetic Retinopathy and Age-Related Macular Degeneration: Evaluating Dazdotuftide as a Promising Multitarget Therapeutic Candidate.”
Investor Relations Tarsier Pharma